Joe Biden to Announce Distribution Plan For 80 Million Vaccines
United States President Joe Biden will soon announce the details of the plan to export 80 million Covid-19 vaccine doses to other countries “without any...
Tag : Covaxin
Delhi HC Bangs AAP Government Over Covaxin Shortage
The Delhi High Court, on June 2, rapped the Aam Aadmi Party (AAP) government for not being able to provide a second dose of Bharat...
Kerala Announces Vaccine Certificate for People Travelling Abroad
The government of Kerala has announced that it will issue vaccine certificates to people traveling abroad. The government said that beneficiaries may apply for a...
Bharat Biotech to Start Trials of Covaxin 2 to 18 Age Group
The Phase 2-3 clinical trials of Covid-19 vaccine, Covaxin, has been approved by the Drugs Controller General of India (DCGI), for in the age group...
Vaccine Makers Invited To Produce Covaxin
The central government and Bharat Biotech are willing to invite other companies which want to produce Covaxin to help scale up its production, a top...
Covishield, Covaxin Effective Against ‘Indian Strain’ of Corona
Covishield and Covaxin, the two coronavirus vaccines currently in use in India have efficacy against the ‘Indian strain’ and show ‘milder’ illness in case of...
Covaxin to be Sold at Rs 600 to States, Rs 1,200 to Pvt Hospitals
Bharat Biotech announced on April 24 that its COVID-19 vaccine Covaxin will be sold at Rs 600 per dose to states, and Rs 1,200 per...
PM Gets Second Dose of COVID-19 Vaccine
Prime Minister Narendra Modi received his second dose of the Covid vaccine today at AIIMS Delhi – 37 days after his first shot – and...
Ocugen Seeks to Sell 100 Mn Bharat Biotech’s Covaxin Doses in US in 2021
Ocugen Inc seeks to sell 100 million doses of India’s state-backed COVID-19 vaccine COVAXIN in the United States this year, the U.S. firm’s chief executive...
Ocugen Seeks to Sell 100 Mn Bharat Biotech’s Covaxin Doses in US in 2021
Ocugen Inc seeks to sell 100 million doses of India’s state-backed COVID-19 vaccine COVAXIN in the United States this year, the US firm’s Chief Executive...